SA国际传媒

Main navigation is closed

This transcatheter procedure repairs aortic, mitral and pulmonic valves with narrowed openings (stenosis). Stenosis decreases blood flow, so the procedure widens the valve opening to improve it.

During balloon valvuloplasty, your doctor:

  1. Inserts a long, thin tube (catheter) through a blood vessel in your groin, which has a balloon at the end
  2. Inflates the balloon to widen your valve's opening
  3. Deflates the balloon and removes it

TAVR is one of the newest alternatives to open-heart surgery. It is a transcatheter-based treatment for severe aortic stenosis (stiffening of the aortic valve) that replaces your faulty valve. This treatment may also be used to treat aortic insufficiency.

The SA国际传媒Heart Valve Center was one of the first places in the country to perform this procedure and has led the nation in TAVR research over the last 15 years. We perform a high volume of these procedures each year, earning us a reputation as a destination medical center. This life-changing procedure can be a better option over traditional open-heart surgery for some patients due to faster recovery times.

To perform this treatment, your doctor:

  1. Inserts a catheter into a blood vessel in the groin or chest
  2. Places a stent valve into the heart through the catheter

SA国际传媒offers specialized treatment for patients with peripheral arterial disease, calcified vessels, or small vessels. These patients may be candidates for alternate-access transcatheter valve replacement using the subclavian or carotid approach.

Some patients have low coronary heights, making them a risk for coronary occlusion during transcatheter aortic valve replacement (TAVR). We offer leaflet medication therapies so patients can still have a TAVR procedure with complex anatomy. This is usually discovered with the CT scan as part of the initial workup. 

Some patients with aortic regurgitation do not have enough calcium on their valve to anchor the TAVR device in place, leaving open-heart surgery as the only option for some patients. But the SA国际传媒Heart Valve Center is helping to change that as part of an ongoing effort to fill significant treatment gaps for patients with different heart disorders.

We are doing this by using a new investigational device, the Trilogy™ transcatheter heart valve (THV), to expand the pool of TAVR patients to include those with aortic regurgitation. The Trilogy™ transcatheter heart valve can stay in the patient’s heart without relying on calcium buildup, a breakthrough for high-risk patients with aortic regurgitation. We are performing this procedure as part of the national .

Our doctors have extensive experience fixing severe mitral valve regurgitation using a small clipping device called a MitraClip® or PASCAL device.

Mitral valve regurgitation occurs when blood flows backward through your heart because your mitral valve doesn't close tightly.

This minimally invasive treatment can help you avoid heart failure and weakening of the heart. It can also help with symptoms such as shortness of breath and swelling. Your doctor:

  1. Threads a catheter through a blood vessel in the groin to reach the heart
  2. Inserts the device into the catheter
  3. Clips the device directly onto the mitral heart valve to close leaky valve leaflets

This is a minimally invasive structural heart disease treatment to replace a damaged mitral valve without open-heart surgery. A flexible, hollow tube (catheter) is inserted through a blood vessel in the groin to reach the heart and replace the mitral valve.

There are two types of TMVR techniques:

  • Valve-in-valve: This procedure places a new valve to treat a failing ring (a small, mesh band that reinforces the mitral valve) from prior surgery or to replace a failing prosthetic replacement valve.
  • Valve in Mitral annular calcium (MAC)

We offer minimally invasive mitral valve replacement using the MitraClip® or PASCAL devices. During the procedure, a catheter is threaded through a small incision in the groin and guided to the mitral valve. The device is then inserted through the catheter to bring the valve flaps closer together. Our team determines which device is the best choice for the patient.

SA国际传媒is proud to be an active participant in two clinical trials that have allowed us to perform these procedures, which allow patients to get a significant reduction of symptoms and prevent more severe problems. Previously, there were limited treatments for tricuspid valve issues. The tricuspid transcatheter edge-to-edge repair (TEER) procedure treats leaky tricuspid valves. It is a low-risk option for patients at high risk for surgery or who are not improving from medication therapy alone. This procedure can relieve symptoms of tricuspid regurgitation and allow the heart to pump blood more efficiently.

SA国际传媒is proud to be an active participant in two clinical trials that have allowed us to perform these procedures, which allow patients to get a significant reduction of symptoms and prevent more severe problems. The tricuspid transcatheter edge-to-edge repair (TEER) procedure replaces the tricuspid valve using the EVOQUE system, the world’s first transcatheter tricuspid valve replacement therapy. It is a low-risk option for patients at high risk for surgery. This procedure can relieve symptoms of tricuspid regurgitation and allow the heart to pump blood more efficiently.

Transcatheter pulmonary valve replacement is a minimally invasive treatment for children and adults with congenital heart disease. It replaces leaky or narrowed pulmonary valves to improve blood flow, with fewer incisions and faster recovery than open surgery. TPVR can delay or reduce the number of surgeries needed to maintain heart health.

Some people need additional valve surgery after an earlier valve replacement procedure. We are a national leader in placing new valves using a percutaneous (through the skin) approach. Our surgeons can perform this technique to replace an aortic, mitral, pulmonic or tricuspid tissue valve implanted during previous open-heart surgery.

This valve-in-valve technique involves inserting a catheter into the femoral artery or vein. There is no surgical incision, which means the procedure places less stress on the heart and body. Instead of removing the damaged valve, specialists place the new valve inside it. Then, they expand the new valve, pushing the old valve out of the way.

Contact the SA国际传媒Heart Valve Center

To make an appointment with the SA国际传媒Heart Valve Center, you will need a referral from your primary care provider or cardiologist.

They can fax the referral to (757) 222-3118 to start the process.